Health Care & Life Sciences » Pharmaceuticals | AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals Inc. | Ownership

Companies that own AVEO Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Polar Capital LLP
7,552,666
6.22%
-324,763
0.05%
06/30/2018
BlackRock Fund Advisors
6,406,362
5.27%
4,530,566
0%
06/30/2018
RA Capital Management LLC
5,062,759
4.17%
0
0.84%
06/30/2018
The Vanguard Group, Inc.
4,836,369
3.98%
340,404
0%
06/30/2018
Millennium Management LLC
2,512,016
2.06%
-1,644,071
0.01%
06/30/2018
683 Capital Management LLC
2,500,000
2.06%
0
0.85%
06/30/2018
Perceptive Advisors LLC
1,891,192
1.56%
-566,924
0.13%
06/30/2018
SSgA Funds Management, Inc.
1,559,906
1.28%
1,418,566
0%
06/30/2018
Northern Trust Investments, Inc.
1,098,075
0.9%
876,703
0%
06/30/2018
Geode Capital Management LLC
978,544
0.81%
310,588
0%
06/30/2018

About AVEO Pharmaceuticals

View Profile
Address
One Broadway
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.aveooncology.com
Updated 07/08/2019
AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. The company was founded by Ronald A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.